1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. North Carolina >
  6. Glooko Acquires Monarch Medical

M&A Deal Summary

Glooko Acquires Monarch Medical

On September 23, 2025, Glooko acquired software company Monarch Medical

Acquisition Highlights
  • This is Glooko’s 1st transaction in the Software sector.
  • This is Glooko’s 1st transaction in the United States.
  • This is Glooko’s 1st transaction in North Carolina.

M&A Deal Summary
Date 2025-09-23
Target Monarch Medical
Sector Software
Buyer(s) Glooko
Deal Type Add-on Acquisition

Target

Monarch Medical

Charlotte, North Carolina, United States
Monarch Medical operates EndoTool Glucose Management System, an enterprise solution for inpatient glycemic control. The company improves patient safety and outcomes through precise insulin dosing technology. Its platform has been adopted by hospitals and health systems across the United States to standardize and optimize insulin therapy, virtually eliminating severe hypoglycemia and reducing hyperglycemia in critical care settings. Monarch Medical is based in Charlotte, North Carolina.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Glooko

Palo Alto, California, United States
Category Company
Founded 2010
Sector Software
DESCRIPTION

Glooko is a provider of remote patient monitoring and digital health solutions for diabetes and other chronic conditions. The company's software platforms collect and analyze data from multiple devices in one highly secure place, allowing for easy remote upload via app or in-clinic, and producing easy-to-read analytics through actionable charts and graphs. Glooko was founded in 2010 and is based in Palo Alto, California.

DEAL STATS #
Overall 3 of 3
Sector: Software M&A 1 of 1
Type: Add-on Acquisition M&A Deals 3 of 3
State: North Carolina M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-03-16 Diabnext

Paris, France

Diabnext is a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers. Diabnext's mobile app complements Glooko’s product portfolio and tracks diabetes data so that physicians can collaborate with their patients to monitor individual patient data and provide remote care. Diabnext is based in Paris, France.

Buy -
Mergr

Solution for

Product

Company

Legal